12/4
04:30 pm
trda
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/17
09:32 am
trda
Entrada Therapeutics: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts [Seeking Alpha]
Low
Report
Entrada Therapeutics: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts [Seeking Alpha]
11/6
09:01 pm
trda
Entrada Therapeutics (NASDAQ:TRDA) was given a new $13.00 price target on by analysts at Roth Capital.
Low
Report
Entrada Therapeutics (NASDAQ:TRDA) was given a new $13.00 price target on by analysts at Roth Capital.
11/6
07:23 am
trda
Entrada Therapeutics Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Low
Report
Entrada Therapeutics Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/6
07:00 am
trda
Entrada Therapeutics Reports Third Quarter 2025 Financial Results
Low
Report
Entrada Therapeutics Reports Third Quarter 2025 Financial Results
10/28
07:00 am
trda
Entrada Therapeutics to Present at Upcoming Investor Conferences
Low
Report
Entrada Therapeutics to Present at Upcoming Investor Conferences
10/3
03:35 pm
trda
Entrada Therapeutics (NASDAQ:TRDA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
Low
Report
Entrada Therapeutics (NASDAQ:TRDA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
9/25
03:38 pm
trda
Entrada Therapeutics, Inc. (TRDA) Discusses On Home With HCW Call (Transcript) [Seeking Alpha]
Low
Report
Entrada Therapeutics, Inc. (TRDA) Discusses On Home With HCW Call (Transcript) [Seeking Alpha]
11/6/2025
07:00 am
TRDA
entrada therapeutics, inc.
MISS
Report
0.6%
entrada therapeutics, inc.
5/8/2025
07:00 am
TRDA
entrada therapeutics, inc.
BEAT
Report
6.2%
entrada therapeutics, inc.
12/4
06:03 am
trda
Form EFFECT Entrada Therapeutics,
Low
Report
Form EFFECT Entrada Therapeutics,
11/25
04:29 pm
trda
Form SCHEDULE 13G Entrada Therapeutics, Filed by: TCG Crossover GP I, LLC
Low
Report
Form SCHEDULE 13G Entrada Therapeutics, Filed by: TCG Crossover GP I, LLC
11/24
04:31 pm
trda
Form 4 Entrada Therapeutics, For: Nov 21 Filed by: WENTWORTH KORY JAMES
Low
Report
Form 4 Entrada Therapeutics, For: Nov 21 Filed by: WENTWORTH KORY JAMES
11/24
04:10 pm
trda
Form 4 Entrada Therapeutics, For: Nov 20 Filed by: BAKER BROS. ADVISORS LP
Low
Report
Form 4 Entrada Therapeutics, For: Nov 20 Filed by: BAKER BROS. ADVISORS LP
11/21
04:46 pm
trda
Form 144 Entrada Therapeutics, Filed by: WENTWORTH KORY JAMES
Low
Report
Form 144 Entrada Therapeutics, Filed by: WENTWORTH KORY JAMES
11/18
04:38 pm
trda
Form SCHEDULE 13D/A Entrada Therapeutics, Filed by: 5AM Ventures V, L.P.
Low
Report
Form SCHEDULE 13D/A Entrada Therapeutics, Filed by: 5AM Ventures V, L.P.
11/18
04:36 pm
trda
Form 4 Entrada Therapeutics, For: Nov 14 Filed by: PARMAR KUSH
Low
Report
Form 4 Entrada Therapeutics, For: Nov 14 Filed by: PARMAR KUSH
11/18
04:35 pm
trda
Form 4 Entrada Therapeutics, For: Nov 14 Filed by: ROCKLAGE SCOTT M
Low
Report
Form 4 Entrada Therapeutics, For: Nov 14 Filed by: ROCKLAGE SCOTT M
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register